Global (United States, European Union and China) Contrast Injector Systems
Global (United States, European Union and China) Contrast Injector Systems

Contrast Injector Systems Comprehensive Study by Type (CT Injector Systems, MRI Injector Systems, Angiography Injector Systems), Application (Interventional Radiology, Interventional Cardiology, Radiology), End users (Diagnostics Centers, Clinics, Hospitals, Others) Players and Region - Global Market Outlook to 2024

Contrast Injector Systems Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Oct 2019 Edition 246 Pages 180 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Key Players of Contrast Injector Systems Market Study:
Bracco (Italy), Bayer AG (Germany), Guerbet Group (France), Medtron AG (Germany), Ulrich GmbH & Co. KG (Germany), GE Healthcare (United States), Shenzhen Seacrown Electromechanical (China), Nemoto Kyorindo (Japan), Sino Medical- Device Technology (China) and Vivid Imaging (United States)

In the last few years, Global market of Contrast Injector Systems developed rapidly. Major factors driving the market are Rising Prevalence of Cardiac Diseases Such as Heart Valve Disease .

On the basis of product type, the Contrast Injector Systems market is segmented by CT Injector Systems, MRI Injector Systems and Angiography Injector Systems.

On the basis of applications, the Contrast Injector Systems market is segmented by Interventional Radiology, Interventional Cardiology and Radiology.

Some of the other players that are also part of study are Network Imaging Systems (United States), IRadimed Corporation (United States), Covidien (Ireland) and Agito Medical (Denmark). The Global Contrast Injector Systems market is gaining huge competition due to involvement of United States companies that constantly invest in research & development to meet market expectation with new innovation.

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Contrast Injector Systems market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Contrast Injector Systems market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organisations.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • CT Injector Systems
  • MRI Injector Systems
  • Angiography Injector Systems
By Application
  • Interventional Radiology
  • Interventional Cardiology
  • Radiology
By End users
  • Diagnostics Centers
  • Clinics
  • Hospitals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Cardiac Diseases Such as Heart Valve Disease
      • 3.2.2. Growing Demand for Minimally Invasive Surgeries
    • 3.3. Market Challenges
      • 3.3.1. Stiff Competition among the Major Players
      • 3.3.2. Usage of Injector Systems May Lead to Health Effects
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Contrast Injector Systems
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Contrast Injector Systems, by Type, Application, End users and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Contrast Injector Systems (Value)
      • 5.2.1. Global Contrast Injector Systems by: Type (Value)
        • 5.2.1.1. CT Injector Systems
        • 5.2.1.2. MRI Injector Systems
        • 5.2.1.3. Angiography Injector Systems
      • 5.2.2. Global Contrast Injector Systems by: Application (Value)
        • 5.2.2.1. Interventional Radiology
        • 5.2.2.2. Interventional Cardiology
        • 5.2.2.3. Radiology
      • 5.2.3. Global Contrast Injector Systems by: End users (Value)
        • 5.2.3.1. Diagnostics Centers
        • 5.2.3.2. Clinics
        • 5.2.3.3. Hospitals
        • 5.2.3.4. Others
      • 5.2.4. Global Contrast Injector Systems Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Contrast Injector Systems (Price)
      • 5.3.1. Global Contrast Injector Systems by: Type (Price)
  • 6. Contrast Injector Systems: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bracco (Italy)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Guerbet Group (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medtron AG (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Ulrich GmbH & Co. KG (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GE Healthcare (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Shenzhen Seacrown Electromechanical (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Nemoto Kyorindo (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sino Medical- Device Technology (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Vivid Imaging (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Contrast Injector Systems Sale, by Type, Application, End users and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Contrast Injector Systems (Value)
      • 7.2.1. Global Contrast Injector Systems by: Type (Value)
        • 7.2.1.1. CT Injector Systems
        • 7.2.1.2. MRI Injector Systems
        • 7.2.1.3. Angiography Injector Systems
      • 7.2.2. Global Contrast Injector Systems by: Application (Value)
        • 7.2.2.1. Interventional Radiology
        • 7.2.2.2. Interventional Cardiology
        • 7.2.2.3. Radiology
      • 7.2.3. Global Contrast Injector Systems by: End users (Value)
        • 7.2.3.1. Diagnostics Centers
        • 7.2.3.2. Clinics
        • 7.2.3.3. Hospitals
        • 7.2.3.4. Others
      • 7.2.4. Global Contrast Injector Systems Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Contrast Injector Systems (Price)
      • 7.3.1. Global Contrast Injector Systems by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Contrast Injector Systems: by Type(USD Million)
  • Table 2. Contrast Injector Systems CT Injector Systems , by Region USD Million (2013-2018)
  • Table 3. Contrast Injector Systems MRI Injector Systems , by Region USD Million (2013-2018)
  • Table 4. Contrast Injector Systems Angiography Injector Systems , by Region USD Million (2013-2018)
  • Table 5. Contrast Injector Systems: by Application(USD Million)
  • Table 6. Contrast Injector Systems Interventional Radiology , by Region USD Million (2013-2018)
  • Table 7. Contrast Injector Systems Interventional Cardiology , by Region USD Million (2013-2018)
  • Table 8. Contrast Injector Systems Radiology , by Region USD Million (2013-2018)
  • Table 9. Contrast Injector Systems: by End users(USD Million)
  • Table 10. Contrast Injector Systems Diagnostics Centers , by Region USD Million (2013-2018)
  • Table 11. Contrast Injector Systems Clinics , by Region USD Million (2013-2018)
  • Table 12. Contrast Injector Systems Hospitals , by Region USD Million (2013-2018)
  • Table 13. Contrast Injector Systems Others , by Region USD Million (2013-2018)
  • Table 14. South America Contrast Injector Systems, by Country USD Million (2013-2018)
  • Table 15. South America Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 16. South America Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 17. South America Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 18. Brazil Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 19. Brazil Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 20. Brazil Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 21. Argentina Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 22. Argentina Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 23. Argentina Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 24. Rest of South America Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 25. Rest of South America Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 26. Rest of South America Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 27. Asia Pacific Contrast Injector Systems, by Country USD Million (2013-2018)
  • Table 28. Asia Pacific Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 29. Asia Pacific Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 30. Asia Pacific Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 31. China Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 32. China Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 33. China Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 34. Japan Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 35. Japan Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 36. Japan Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 37. India Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 38. India Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 39. India Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 40. South Korea Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 41. South Korea Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 42. South Korea Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 43. Taiwan Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 44. Taiwan Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 45. Taiwan Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 46. Australia Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 47. Australia Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 48. Australia Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 49. Rest of Asia-Pacific Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 50. Rest of Asia-Pacific Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 51. Rest of Asia-Pacific Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 52. Europe Contrast Injector Systems, by Country USD Million (2013-2018)
  • Table 53. Europe Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 54. Europe Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 55. Europe Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 56. Germany Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 57. Germany Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 58. Germany Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 59. France Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 60. France Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 61. France Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 62. Italy Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 63. Italy Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 64. Italy Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 65. United Kingdom Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 66. United Kingdom Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 67. United Kingdom Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 68. Netherlands Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 69. Netherlands Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 70. Netherlands Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 71. Rest of Europe Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 72. Rest of Europe Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 73. Rest of Europe Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 74. MEA Contrast Injector Systems, by Country USD Million (2013-2018)
  • Table 75. MEA Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 76. MEA Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 77. MEA Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 78. Middle East Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 79. Middle East Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 80. Middle East Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 81. Africa Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 82. Africa Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 83. Africa Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 84. North America Contrast Injector Systems, by Country USD Million (2013-2018)
  • Table 85. North America Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 86. North America Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 87. North America Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 88. United States Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 89. United States Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 90. United States Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 91. Canada Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 92. Canada Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 93. Canada Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 94. Mexico Contrast Injector Systems, by Type USD Million (2013-2018)
  • Table 95. Mexico Contrast Injector Systems, by Application USD Million (2013-2018)
  • Table 96. Mexico Contrast Injector Systems, by End users USD Million (2013-2018)
  • Table 97. Contrast Injector Systems: by Type(USD/Units)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Contrast Injector Systems: by Type(USD Million)
  • Table 109. Contrast Injector Systems CT Injector Systems , by Region USD Million (2019-2024)
  • Table 110. Contrast Injector Systems MRI Injector Systems , by Region USD Million (2019-2024)
  • Table 111. Contrast Injector Systems Angiography Injector Systems , by Region USD Million (2019-2024)
  • Table 112. Contrast Injector Systems: by Application(USD Million)
  • Table 113. Contrast Injector Systems Interventional Radiology , by Region USD Million (2019-2024)
  • Table 114. Contrast Injector Systems Interventional Cardiology , by Region USD Million (2019-2024)
  • Table 115. Contrast Injector Systems Radiology , by Region USD Million (2019-2024)
  • Table 116. Contrast Injector Systems: by End users(USD Million)
  • Table 117. Contrast Injector Systems Diagnostics Centers , by Region USD Million (2019-2024)
  • Table 118. Contrast Injector Systems Clinics , by Region USD Million (2019-2024)
  • Table 119. Contrast Injector Systems Hospitals , by Region USD Million (2019-2024)
  • Table 120. Contrast Injector Systems Others , by Region USD Million (2019-2024)
  • Table 121. South America Contrast Injector Systems, by Country USD Million (2019-2024)
  • Table 122. South America Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 123. South America Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 124. South America Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 125. Brazil Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 126. Brazil Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 127. Brazil Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 128. Argentina Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 129. Argentina Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 130. Argentina Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 131. Rest of South America Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 132. Rest of South America Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 133. Rest of South America Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 134. Asia Pacific Contrast Injector Systems, by Country USD Million (2019-2024)
  • Table 135. Asia Pacific Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 136. Asia Pacific Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 137. Asia Pacific Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 138. China Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 139. China Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 140. China Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 141. Japan Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 142. Japan Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 143. Japan Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 144. India Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 145. India Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 146. India Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 147. South Korea Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 148. South Korea Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 149. South Korea Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 150. Taiwan Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 151. Taiwan Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 152. Taiwan Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 153. Australia Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 154. Australia Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 155. Australia Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 156. Rest of Asia-Pacific Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 157. Rest of Asia-Pacific Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 158. Rest of Asia-Pacific Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 159. Europe Contrast Injector Systems, by Country USD Million (2019-2024)
  • Table 160. Europe Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 161. Europe Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 162. Europe Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 163. Germany Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 164. Germany Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 165. Germany Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 166. France Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 167. France Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 168. France Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 169. Italy Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 170. Italy Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 171. Italy Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 172. United Kingdom Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 173. United Kingdom Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 174. United Kingdom Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 175. Netherlands Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 176. Netherlands Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 177. Netherlands Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 178. Rest of Europe Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 179. Rest of Europe Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 180. Rest of Europe Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 181. MEA Contrast Injector Systems, by Country USD Million (2019-2024)
  • Table 182. MEA Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 183. MEA Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 184. MEA Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 185. Middle East Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 186. Middle East Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 187. Middle East Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 188. Africa Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 189. Africa Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 190. Africa Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 191. North America Contrast Injector Systems, by Country USD Million (2019-2024)
  • Table 192. North America Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 193. North America Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 194. North America Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 195. United States Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 196. United States Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 197. United States Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 198. Canada Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 199. Canada Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 200. Canada Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 201. Mexico Contrast Injector Systems, by Type USD Million (2019-2024)
  • Table 202. Mexico Contrast Injector Systems, by Application USD Million (2019-2024)
  • Table 203. Mexico Contrast Injector Systems, by End users USD Million (2019-2024)
  • Table 204. Contrast Injector Systems: by Type(USD/Units)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Contrast Injector Systems: by Type USD Million (2013-2018)
  • Figure 5. Global Contrast Injector Systems: by Application USD Million (2013-2018)
  • Figure 6. Global Contrast Injector Systems: by End users USD Million (2013-2018)
  • Figure 7. South America Contrast Injector Systems Share (%), by Country
  • Figure 8. Asia Pacific Contrast Injector Systems Share (%), by Country
  • Figure 9. Europe Contrast Injector Systems Share (%), by Country
  • Figure 10. MEA Contrast Injector Systems Share (%), by Country
  • Figure 11. North America Contrast Injector Systems Share (%), by Country
  • Figure 12. Global Contrast Injector Systems: by Type USD/Units (2013-2018)
  • Figure 13. Global Contrast Injector Systems share by Players 2018 (%)
  • Figure 14. Global Contrast Injector Systems share by Players (Top 3) 2018(%)
  • Figure 15. Global Contrast Injector Systems share by Players (Top 5) 2018(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bracco (Italy) Revenue, Net Income and Gross profit
  • Figure 18. Bracco (Italy) Revenue: by Geography 2018
  • Figure 19. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Bayer AG (Germany) Revenue: by Geography 2018
  • Figure 21. Guerbet Group (France) Revenue, Net Income and Gross profit
  • Figure 22. Guerbet Group (France) Revenue: by Geography 2018
  • Figure 23. Medtron AG (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Medtron AG (Germany) Revenue: by Geography 2018
  • Figure 25. Ulrich GmbH & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Ulrich GmbH & Co. KG (Germany) Revenue: by Geography 2018
  • Figure 27. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 28. GE Healthcare (United States) Revenue: by Geography 2018
  • Figure 29. Shenzhen Seacrown Electromechanical (China) Revenue, Net Income and Gross profit
  • Figure 30. Shenzhen Seacrown Electromechanical (China) Revenue: by Geography 2018
  • Figure 31. Nemoto Kyorindo (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Nemoto Kyorindo (Japan) Revenue: by Geography 2018
  • Figure 33. Sino Medical- Device Technology (China) Revenue, Net Income and Gross profit
  • Figure 34. Sino Medical- Device Technology (China) Revenue: by Geography 2018
  • Figure 35. Vivid Imaging (United States) Revenue, Net Income and Gross profit
  • Figure 36. Vivid Imaging (United States) Revenue: by Geography 2018
  • Figure 37. Global Contrast Injector Systems: by Type USD Million (2019-2024)
  • Figure 38. Global Contrast Injector Systems: by Application USD Million (2019-2024)
  • Figure 39. Global Contrast Injector Systems: by End users USD Million (2019-2024)
  • Figure 40. South America Contrast Injector Systems Share (%), by Country
  • Figure 41. Asia Pacific Contrast Injector Systems Share (%), by Country
  • Figure 42. Europe Contrast Injector Systems Share (%), by Country
  • Figure 43. MEA Contrast Injector Systems Share (%), by Country
  • Figure 44. North America Contrast Injector Systems Share (%), by Country
  • Figure 45. Global Contrast Injector Systems: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • Bracco (Italy)
  • Bayer AG (Germany)
  • Guerbet Group (France)
  • Medtron AG (Germany)
  • Ulrich GmbH & Co. KG (Germany)
  • GE Healthcare (United States)
  • Shenzhen Seacrown Electromechanical (China)
  • Nemoto Kyorindo (Japan)
  • Sino Medical- Device Technology (China)
  • Vivid Imaging (United States)
Additional players considered in the study are as follows:
Network Imaging Systems (United States) , IRadimed Corporation (United States) , Covidien (Ireland) , Agito Medical (Denmark)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation